Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Buy
51
TBRG Quote, Financials, Valuation and Earnings
Last price:
$21.50
Seasonality move
:
6.1%
Day range:
$21.38 - $22.99
52-week range:
$17.86 - $32.00
Dividend yield:
0%
P/E ratio:
121.78x
P/S ratio:
0.95x
P/B ratio:
1.89x
Volume:
76.7K
Avg. volume:
89.1K
1-year change:
5.58%
Market cap:
$340.7M
Revenue:
$342.6M
EPS (TTM):
$0.19
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
TBRG
TruBridge, Inc.
|
$87.6M | $0.66 | 0.28% | -28.23% | $22.60 |
|
CDT
CDT Equity, Inc.
|
-- | -- | -- | -- | -- |
|
LENZ
LENZ Therapeutics, Inc.
|
$1.5M | -$0.96 | -7.14% | -109.39% | $52.67 |
|
LFMD
LifeMD, Inc.
|
$48.6M | $0.01 | -24.41% | -93.33% | $9.25 |
|
MDRX
Veradigm, Inc.
|
$149.7M | $0.08 | -- | -- | $5.83 |
|
STRM
Streamline Health Solutions,
|
$5.3M | -- | -24.87% | -- | $22.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
TBRG
TruBridge, Inc.
|
$22.70 | $22.60 | $340.7M | 121.78x | $0.00 | 0% | 0.95x |
|
CDT
CDT Equity, Inc.
|
$1.51 | -- | $2.5M | -- | $0.00 | 0% | -- |
|
LENZ
LENZ Therapeutics, Inc.
|
$15.24 | $52.67 | $476.9M | -- | $1.03 | 0% | 24.31x |
|
LFMD
LifeMD, Inc.
|
$4.00 | $9.25 | $192.5M | -- | $0.00 | 0% | 0.71x |
|
MDRX
Veradigm, Inc.
|
$4.85 | $5.83 | $525.1M | -- | $0.00 | 0% | 0.90x |
|
STRM
Streamline Health Solutions,
|
$5.34 | $22.50 | $23.3M | -- | $0.00 | 0% | 1.18x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
TBRG
TruBridge, Inc.
|
48.06% | -0.370 | 55.15% | 1.44x |
|
CDT
CDT Equity, Inc.
|
30.47% | -0.944 | 27% | 1.13x |
|
LENZ
LENZ Therapeutics, Inc.
|
0.49% | -0.162 | 0.07% | 12.39x |
|
LFMD
LifeMD, Inc.
|
83.24% | 2.884 | 2.29% | 0.58x |
|
MDRX
Veradigm, Inc.
|
-- | 0.948 | -- | -- |
|
STRM
Streamline Health Solutions,
|
55.84% | 4.014 | 109.22% | 0.25x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
TBRG
TruBridge, Inc.
|
$37.3M | $7.8M | 0.81% | 1.61% | 9.01% | $9.3M |
|
CDT
CDT Equity, Inc.
|
-$885K | -$7M | -898.82% | -- | -- | -$4.4M |
|
LENZ
LENZ Therapeutics, Inc.
|
$12.4M | -$18.9M | -28.93% | -29.1% | -151.1% | -$9M |
|
LFMD
LifeMD, Inc.
|
$50M | -$2M | -15.29% | -- | -3.27% | -$3.7M |
|
MDRX
Veradigm, Inc.
|
-- | -- | -- | -- | -- | -- |
|
STRM
Streamline Health Solutions,
|
$2.6M | -$1.1M | -33.65% | -64.34% | -22.91% | -$1.2M |
TruBridge, Inc. vs. Competitors
-
Which has Higher Returns TBRG or CDT?
CDT Equity, Inc. has a net margin of 6.3% compared to TruBridge, Inc.'s net margin of --. TruBridge, Inc.'s return on equity of 1.61% beat CDT Equity, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital TBRGTruBridge, Inc.43.35% $0.37 $347.2M CDTCDT Equity, Inc.-- -$13.16 $6.2M -
What do Analysts Say About TBRG or CDT?
TruBridge, Inc. has a consensus price target of $22.60, signalling downside risk potential of -0.44%. On the other hand CDT Equity, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that TruBridge, Inc. has higher upside potential than CDT Equity, Inc., analysts believe TruBridge, Inc. is more attractive than CDT Equity, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TBRGTruBridge, Inc.2 3 0 CDTCDT Equity, Inc.0 0 0 -
Is TBRG or CDT More Risky?
TruBridge, Inc. has a beta of 0.607, which suggesting that the stock is 39.29% less volatile than S&P 500. In comparison CDT Equity, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock TBRG or CDT?
TruBridge, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CDT Equity, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TruBridge, Inc. pays -- of its earnings as a dividend. CDT Equity, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TBRG or CDT?
TruBridge, Inc. quarterly revenues are $86.1M, which are larger than CDT Equity, Inc. quarterly revenues of --. TruBridge, Inc.'s net income of $5.4M is higher than CDT Equity, Inc.'s net income of -$7.1M. Notably, TruBridge, Inc.'s price-to-earnings ratio is 121.78x while CDT Equity, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TruBridge, Inc. is 0.95x versus -- for CDT Equity, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TBRGTruBridge, Inc.0.95x 121.78x $86.1M $5.4M CDTCDT Equity, Inc.-- -- -- -$7.1M
-
Which has Higher Returns TBRG or LENZ?
LENZ Therapeutics, Inc. has a net margin of 6.3% compared to TruBridge, Inc.'s net margin of -133.6%. TruBridge, Inc.'s return on equity of 1.61% beat LENZ Therapeutics, Inc.'s return on equity of -29.1%.
Company Gross Margin Earnings Per Share Invested Capital TBRGTruBridge, Inc.43.35% $0.37 $347.2M LENZLENZ Therapeutics, Inc.99% -$0.59 $194.9M -
What do Analysts Say About TBRG or LENZ?
TruBridge, Inc. has a consensus price target of $22.60, signalling downside risk potential of -0.44%. On the other hand LENZ Therapeutics, Inc. has an analysts' consensus of $52.67 which suggests that it could grow by 245.58%. Given that LENZ Therapeutics, Inc. has higher upside potential than TruBridge, Inc., analysts believe LENZ Therapeutics, Inc. is more attractive than TruBridge, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TBRGTruBridge, Inc.2 3 0 LENZLENZ Therapeutics, Inc.5 0 0 -
Is TBRG or LENZ More Risky?
TruBridge, Inc. has a beta of 0.607, which suggesting that the stock is 39.29% less volatile than S&P 500. In comparison LENZ Therapeutics, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock TBRG or LENZ?
TruBridge, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENZ Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $1.03 per share. TruBridge, Inc. pays -- of its earnings as a dividend. LENZ Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TBRG or LENZ?
TruBridge, Inc. quarterly revenues are $86.1M, which are larger than LENZ Therapeutics, Inc. quarterly revenues of $12.5M. TruBridge, Inc.'s net income of $5.4M is higher than LENZ Therapeutics, Inc.'s net income of -$16.7M. Notably, TruBridge, Inc.'s price-to-earnings ratio is 121.78x while LENZ Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TruBridge, Inc. is 0.95x versus 24.31x for LENZ Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TBRGTruBridge, Inc.0.95x 121.78x $86.1M $5.4M LENZLENZ Therapeutics, Inc.24.31x -- $12.5M -$16.7M
-
Which has Higher Returns TBRG or LFMD?
LifeMD, Inc. has a net margin of 6.3% compared to TruBridge, Inc.'s net margin of -5.91%. TruBridge, Inc.'s return on equity of 1.61% beat LifeMD, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital TBRGTruBridge, Inc.43.35% $0.37 $347.2M LFMDLifeMD, Inc.83.06% -$0.10 $9.9M -
What do Analysts Say About TBRG or LFMD?
TruBridge, Inc. has a consensus price target of $22.60, signalling downside risk potential of -0.44%. On the other hand LifeMD, Inc. has an analysts' consensus of $9.25 which suggests that it could grow by 131.25%. Given that LifeMD, Inc. has higher upside potential than TruBridge, Inc., analysts believe LifeMD, Inc. is more attractive than TruBridge, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TBRGTruBridge, Inc.2 3 0 LFMDLifeMD, Inc.7 1 0 -
Is TBRG or LFMD More Risky?
TruBridge, Inc. has a beta of 0.607, which suggesting that the stock is 39.29% less volatile than S&P 500. In comparison LifeMD, Inc. has a beta of 1.456, suggesting its more volatile than the S&P 500 by 45.566%.
-
Which is a Better Dividend Stock TBRG or LFMD?
TruBridge, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LifeMD, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TruBridge, Inc. pays -- of its earnings as a dividend. LifeMD, Inc. pays out 16.59% of its earnings as a dividend. LifeMD, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios TBRG or LFMD?
TruBridge, Inc. quarterly revenues are $86.1M, which are larger than LifeMD, Inc. quarterly revenues of $60.2M. TruBridge, Inc.'s net income of $5.4M is higher than LifeMD, Inc.'s net income of -$3.6M. Notably, TruBridge, Inc.'s price-to-earnings ratio is 121.78x while LifeMD, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TruBridge, Inc. is 0.95x versus 0.71x for LifeMD, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TBRGTruBridge, Inc.0.95x 121.78x $86.1M $5.4M LFMDLifeMD, Inc.0.71x -- $60.2M -$3.6M
-
Which has Higher Returns TBRG or MDRX?
Veradigm, Inc. has a net margin of 6.3% compared to TruBridge, Inc.'s net margin of --. TruBridge, Inc.'s return on equity of 1.61% beat Veradigm, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital TBRGTruBridge, Inc.43.35% $0.37 $347.2M MDRXVeradigm, Inc.-- -- -- -
What do Analysts Say About TBRG or MDRX?
TruBridge, Inc. has a consensus price target of $22.60, signalling downside risk potential of -0.44%. On the other hand Veradigm, Inc. has an analysts' consensus of $5.83 which suggests that it could grow by 20.28%. Given that Veradigm, Inc. has higher upside potential than TruBridge, Inc., analysts believe Veradigm, Inc. is more attractive than TruBridge, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TBRGTruBridge, Inc.2 3 0 MDRXVeradigm, Inc.1 2 0 -
Is TBRG or MDRX More Risky?
TruBridge, Inc. has a beta of 0.607, which suggesting that the stock is 39.29% less volatile than S&P 500. In comparison Veradigm, Inc. has a beta of 0.510, suggesting its less volatile than the S&P 500 by 49.042%.
-
Which is a Better Dividend Stock TBRG or MDRX?
TruBridge, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Veradigm, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TruBridge, Inc. pays -- of its earnings as a dividend. Veradigm, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TBRG or MDRX?
TruBridge, Inc. quarterly revenues are $86.1M, which are larger than Veradigm, Inc. quarterly revenues of --. TruBridge, Inc.'s net income of $5.4M is higher than Veradigm, Inc.'s net income of --. Notably, TruBridge, Inc.'s price-to-earnings ratio is 121.78x while Veradigm, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TruBridge, Inc. is 0.95x versus 0.90x for Veradigm, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TBRGTruBridge, Inc.0.95x 121.78x $86.1M $5.4M MDRXVeradigm, Inc.0.90x -- -- --
-
Which has Higher Returns TBRG or STRM?
Streamline Health Solutions, has a net margin of 6.3% compared to TruBridge, Inc.'s net margin of -34.2%. TruBridge, Inc.'s return on equity of 1.61% beat Streamline Health Solutions,'s return on equity of -64.34%.
Company Gross Margin Earnings Per Share Invested Capital TBRGTruBridge, Inc.43.35% $0.37 $347.2M STRMStreamline Health Solutions,53.85% -$0.40 $25M -
What do Analysts Say About TBRG or STRM?
TruBridge, Inc. has a consensus price target of $22.60, signalling downside risk potential of -0.44%. On the other hand Streamline Health Solutions, has an analysts' consensus of $22.50 which suggests that it could fall by -71.91%. Given that Streamline Health Solutions, has more downside risk than TruBridge, Inc., analysts believe TruBridge, Inc. is more attractive than Streamline Health Solutions,.
Company Buy Ratings Hold Ratings Sell Ratings TBRGTruBridge, Inc.2 3 0 STRMStreamline Health Solutions,1 0 0 -
Is TBRG or STRM More Risky?
TruBridge, Inc. has a beta of 0.607, which suggesting that the stock is 39.29% less volatile than S&P 500. In comparison Streamline Health Solutions, has a beta of 2.070, suggesting its more volatile than the S&P 500 by 106.993%.
-
Which is a Better Dividend Stock TBRG or STRM?
TruBridge, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Streamline Health Solutions, offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TruBridge, Inc. pays -- of its earnings as a dividend. Streamline Health Solutions, pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TBRG or STRM?
TruBridge, Inc. quarterly revenues are $86.1M, which are larger than Streamline Health Solutions, quarterly revenues of $4.8M. TruBridge, Inc.'s net income of $5.4M is higher than Streamline Health Solutions,'s net income of -$1.6M. Notably, TruBridge, Inc.'s price-to-earnings ratio is 121.78x while Streamline Health Solutions,'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TruBridge, Inc. is 0.95x versus 1.18x for Streamline Health Solutions,. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TBRGTruBridge, Inc.0.95x 121.78x $86.1M $5.4M STRMStreamline Health Solutions,1.18x -- $4.8M -$1.6M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
65
RGC alert for Jan 10
Regencell Bioscience Holdings Ltd. [RGC] is up 10.55% over the past day.
Sell
50
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
